JanOne recently announced that it has forged a partnership with a company to bottle and label its JAN101 drug. JanOne said it is preparing its investigational new drug application for FDA submission as a potential treatment for vascular complications caused by COVID-19. The drug is already planned for use in Phase 2b trials as a…